Form CORRESP - Correspondence:
SEC Accession No. 0001193125-21-123974
Filing Date
2021-04-21
Accepted
2021-04-21 10:14:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 66440
  Complete submission text file 0001193125-21-123974.txt   67534
Mailing Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH
Business Address THE DOROTHY HODGKIN BUILDING BABRAHAM RESEARCH CAMPUS BABRAHAM, CAMBRIDGE X0 CB22 3FH 44 (0)7767 003904
Centessa Pharmaceuticals Ltd (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations